about
Sucrose, high-fructose corn syrup, and fructose, their metabolism and potential health effects: what do we really know?Effect of allopurinol in chronic kidney disease progression and cardiovascular riskTherapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinolFructose consumption as a risk factor for non-alcoholic fatty liver diseaseUric acid in metabolic syndrome: From an innocent bystander to a central playerHyperuricemia: A Biomarker of Renal Hemodynamic ImpairmentUric acid, hyperuricemia and vascular diseasesHypertension and chronic kidney disease: controversies in pathogenesis and treatmentPrinciples of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in diseaseAre either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisalMechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and goutSoft drinks consumption and nonalcoholic fatty liver diseaseRole of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic SteatohepatitisUrinary polycyclic aromatic hydrocarbons and measures of oxidative stress, inflammation and renal function in adolescents: NHANES 2003-2008Association of serum uric acid with 2-hour postload glucose in Chinese with impaired fasting plasma glucose and/or HbA1cGeraniol, alone and in combination with pioglitazone, ameliorates fructose-induced metabolic syndrome in rats via the modulation of both inflammatory and oxidative stress statusPreeclampsia Is Associated with Increased Central Aortic Pressure, Elastic Arteries Stiffness and Wave Reflections, and Resting and Recruitable Endothelial DysfunctionAbility among adolescents for the metabolic syndrome to predict elevations in factors associated with type 2 diabetes and cardiovascular disease: data from the national health and nutrition examination survey 1999-2006Effects of menopause and hormone replacement therapy on the associations of hyperuricemia with mortality.Effect of allopurinol on blood pressure: a systematic review and meta-analysis.Serum uric acid change and modification of blood pressure and fasting plasma glucose in an overall healthy population sample: data from the Brisighella heart study.Association of diabetes mellitus with decline in ankle-brachial index among patients on hemodialysis: A 6-year follow-up studyAsymptomatic hyperuricemia is independently associated with coronary artery calcification in the absence of overt coronary artery disease: A single-center cross-sectional studyAn observational study on the relationship between serum uric acid and hypertension in a Northern Chinese population aged 45 to 59 years.Early onset hyperuricemia is a prognostic marker for kidney graft failure: Propensity score matching analysis in a Korean multicenter cohort.Hyperuricemia and incident hypertension: a systematic review and meta-analysis.Uric acid: the past decadePhysiological concentrations of soluble uric acid are chondroprotective and anti-inflammatory.Protective role of α-lipoic acid in hyperuricemia-induced endothelial dysfunction.Uric acid as one of the important factors in multifactorial disorders--facts and controversies.Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension?Serum uric acid is associated with incident chronic kidney disease in middle-aged populations: a meta-analysis of 15 cohort studies.Hyperuricemia and risk of increased arterial stiffness in healthy women based on health screening in Korean population.Uric acid transport and diseaseUric acid does not affect the acetylcholine-induced relaxation of aorta from normotensive and deoxycorticosterone acetate-salt hypertensive rats.Trajectories of metabolic risk factors and biochemical markers prior to the onset of type 2 diabetes: the population-based longitudinal Doetinchem study.Comparing the effects of inorganic nitrate and allopurinol in renovascular complications of metabolic syndrome in rats: role of nitric oxide and uric acidUric acid inhibition of dipeptidyl peptidase IV in vitro is dependent on the intracellular formation of triuretUric acid: the oxidant-antioxidant paradoxSerum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study.
P2860
Q24629127-B45651B2-DF64-4F29-9648-E007FC3078DEQ24630327-8DCECEF2-A4BE-481A-8736-7BF01083C8C7Q24652967-9FFD76A6-38E4-4730-905E-7E0828CB419FQ24657933-E0F78478-E302-4005-B3F6-46AAAF4A153BQ26772053-A9868683-0732-4CC3-B661-125174A901C2Q26801451-482D983A-F4F9-443E-9DF0-FAE30B3D495DQ26850727-557E7E45-481F-4790-88DF-37E372AA9191Q26851271-92774132-182A-43A2-A4A9-70403010A1ACQ26859449-3FC03B54-910C-4317-B48E-A995FF1F011EQ26862468-0BFDD7B9-866B-488B-9EBE-92CAFCD86C69Q27023909-5B44989D-7F97-47F1-9BF1-314AA8581AF2Q28284041-0F03CF6E-D0A7-47F9-A5E2-E52868FD2039Q28354735-C709B083-6E16-49BD-B4D7-A0AA635C4046Q28396339-A28FD874-441B-4D1D-8066-8634ABE65E9FQ28534505-FE214DF5-CB64-4990-9ADE-BC3B54BA3737Q28543462-B2ED5D0D-B7E2-4A1A-B0F0-FA5B9FC2E24DQ30403325-D54710A6-B10C-4F99-A7DC-B6775D791568Q30431280-D41EF9C0-EE75-453C-9FAF-DA049D6D7EA1Q30601002-BFB5A7CF-1DDD-4D34-8BED-B54989E0B201Q31118679-DEA7B906-D0C8-4FF2-98BA-B2A37E66827FQ31120135-2185E59F-ACBB-4200-92F0-0B786B1D1E87Q33562988-2D24B36E-5FD3-4F0D-8ECB-D399C8B92171Q33621392-480B27F8-578D-4E8D-AE8A-7D1D55CB24A1Q33627251-7385F3F7-5718-4948-85CD-5F2D02672CBAQ33632726-66F61214-66D0-4863-B97B-390F99EF7272Q33687506-C0919AEE-4252-4BEE-BE07-56DCF8880D63Q33690653-BFA34351-BFEA-4AEE-8355-424F71A6BCCDQ33725818-1F4421AB-D25A-4759-B6EB-5E11740E8EBEQ33744192-50BEC055-C57F-464D-AEEB-287C06A26EC3Q33773142-295A9DC4-2EFE-4F72-9496-59112A1812D2Q33790168-F40B0545-2A61-4AFC-9EA8-9457F3F873D7Q33800813-13A85305-24B0-4736-961A-94F69461E744Q33860337-ADB954B2-CF9A-4D03-96CE-B1C83561FD19Q33882958-128C9FBB-4848-4793-A641-B568CAF40A4FQ33890860-32ECA583-2A8D-4F3D-BE37-645B9D8A4EC8Q33920095-DFE342C1-CD31-445B-ADCF-B1AE6797ACDFQ33935273-CCA37303-3958-487C-9EEB-93B13EACF8F9Q33937015-DE30B3A7-1006-4957-B6D4-97D9F7331318Q33956678-C977F0E0-7BE8-469D-B398-82FFD0D00C8CQ33988764-ED5C4B7C-5662-4053-82C2-C1CBFBC18EE3
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Hyperuricemia induces endothelial dysfunction.
@en
Hyperuricemia induces endothelial dysfunction.
@nl
type
label
Hyperuricemia induces endothelial dysfunction.
@en
Hyperuricemia induces endothelial dysfunction.
@nl
prefLabel
Hyperuricemia induces endothelial dysfunction.
@en
Hyperuricemia induces endothelial dysfunction.
@nl
P2093
P1433
P1476
Hyperuricemia induces endothelial dysfunction.
@en
P2093
Carlos Roncal
Edward R Block
Jennifer L Finch
Karina Krotova
Richard J Johnson
Sergey Zharikov
Sharma Prabhakar
Takahiko Nakagawa
Uday M Khosla
P304
P356
10.1111/J.1523-1755.2005.00273.X
P407
P577
2005-05-01T00:00:00Z
P5875
P6179
1043536070